| Suppression of insulin feedback enhances the efficacy of PI3K inhibitors BD Hopkins, C Pauli, X Du, DG Wang, X Li, D Wu, SC Amadiume, ... Nature 560 (7719), 499-503, 2018 | 537 | 2018 |
| Patient derived organoids to model rare prostate cancer phenotypes L Puca, R Bareja, D Prandi, R Shaw, M Benelli, WR Karthaus, J Hess, ... Nature communications 9 (1), 1-10, 2018 | 296 | 2018 |
| Clinical features of neuroendocrine prostate cancer V Conteduca, C Oromendia, KW Eng, R Bareja, M Sigouros, A Molina, ... European journal of cancer 121, 7-18, 2019 | 249 | 2019 |
| A phase II trial of the aurora kinase A inhibitor alisertib for patients with castration resistant and neuroendocrine prostate cancer: efficacy and biomarkers Clinical Cancer Research, clincanres. 1912.2018, 2018 | 206* | 2018 |
| Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling BD Robinson, PJ Vlachostergios, B Bhinder, W Liu, K Li, TJ Moss, ... Nature communications 10 (1), 1-11, 2019 | 168 | 2019 |
| Metastasis and immune evasion from extracellular cGAMP hydrolysis J Li, MA Duran, N Dhanota, WK Chatila, SE Bettigole, J Kwon, RK Sriram, ... Cancer discovery 11 (5), 1212-1227, 2021 | 167 | 2021 |
| N-Myc–mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer A Berger, NJ Brady, R Bareja, B Robinson, V Conteduca, MA Augello, ... The Journal of clinical investigation 129 (9), 3924-3940, 2019 | 143 | 2019 |
| Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets F Tang, D Xu, S Wang, CK Wong, A Martinez-Fundichely, CJ Lee, ... Science 376 (6596), eabe1505, 2022 | 90 | 2022 |
| Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity J Cyrta, A Augspach, MR De Filippo, D Prandi, P Thienger, M Benelli, ... Nature communications 11 (1), 1-16, 2020 | 88 | 2020 |
| Concerted regulation of retinal pigment epithelium basement membrane and barrier function by angiocrine factors I Benedicto, GL Lehmann, M Ginsberg, DJ Nolan, R Bareja, O Elemento, ... Nature communications 8 (1), 1-12, 2017 | 74 | 2017 |
| ZFX mediates non-canonical oncogenic functions of the androgen receptor splice variant 7 in castrate-resistant prostate cancer L Cai, YH Tsai, P Wang, J Wang, D Li, H Fan, Y Zhao, R Bareja, R Lu, ... Molecular cell 72 (2), 341-354. e6, 2018 | 73 | 2018 |
| Obesity-associated extracellular matrix remodeling promotes a macrophage phenotype similar to tumor-associated macrophages NL Springer, NM Iyengar, R Bareja, A Verma, MS Jochelson, DD Giri, ... The American journal of pathology 189 (10), 2019 | 72 | 2019 |
| Rapid identification of BCR/ABL1‐like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time‐polymerase chain … S Chiaretti, M Messina, S Grammatico, A Piciocchi, AL Fedullo, ... British journal of haematology 181 (5), 642-652, 2018 | 59 | 2018 |
| Oncogenic BRAF disrupts thyroid morphogenesis and function via twist expression V Anelli, JA Villefranc, S Chhangawala, R Martinez-McFaline, E Riva, ... Elife 6, e20728, 2017 | 58 | 2017 |
| Single-cell profiling reveals an endothelium-mediated immunomodulatory pathway in the eye choroid GL Lehmann, C Hanke-Gogokhia, Y Hu, R Bareja, Z Salfati, M Ginsberg, ... Journal of Experimental Medicine 217 (6), 2020 | 57 | 2020 |
| SLFN11 expression in advanced prostate cancer and response to platinum-based chemotherapy V Conteduca, SY Ku, L Puca, M Slade, L Fernandez, J Hess, R Bareja, ... Molecular cancer therapeutics 19 (5), 1157-1164, 2020 | 55 | 2020 |
| Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer NJ Brady, AM Bagadion, R Singh, V Conteduca, L Van Emmenis, E Arceci, ... Nature communications 12 (1), 1-17, 2021 | 54 | 2021 |
| Next-generation rapid autopsies enable tumor evolution tracking and generation of preclinical models DJ Pisapia, S Salvatore, C Pauli, E Hissong, K Eng, D Prandi, VW Sailer, ... JCO precision oncology 1, 1-13, 2017 | 52 | 2017 |
| Bone biopsy protocol for advanced prostate cancer in the era of precision medicine V Sailer, MH Schiffman, M Kossai, J Cyrta, S Beg, B Sullivan, BB Pua, ... Cancer 124 (5), 1008-1015, 2018 | 51 | 2018 |
| Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers JP Sfakianos, J Daza, Y Hu, H Anastos, G Bryant, R Bareja, KK Badani, ... Nature communications 11 (1), 1-16, 2020 | 42 | 2020 |
Olivier ElementoDirector, Englander Institute for Precision Medicine, Weill Cornell MedicineDirección de correo verificada de med.cornell.edu
